TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07776210: Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Sponsor: Regenerative Ocular Immunobiologics LLC · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 30 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$1,272,888

Rescue Site Savings

+$848,592

Unlock Full NCT07776210 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07776210 Rescue Dossier →